A bacterium from frog gut microbiota eliminated tumors in mice by selectively colonizing tumors and triggering both direct ...
Cancer cells may be exploiting a common antioxidant as fuel, revealing a potential weakness that future therapies could ...
SurvivorNet on MSN
'Very promising': New cancer drug, Plixorafenib, shows promise for hard‑to‑treat brain tumors as FDA speeds its development
The U.S. Food and Drug Administration (FDA) has granted plixorafenib a Breakthrough Therapy Designation, signaling ...
Morning Overview on MSN
Zeaxanthin may boost anti-tumor immune response in cancer care
Checkpoint inhibitors have transformed cancer treatment over the past decade, helping hundreds of thousands of patients by ...
A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve, shifting from one cancer type to another in ways that may make them more ...
In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health. The findings — which come ...
Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...
It didn’t matter that Eric Tennant’s oncologist had recommended the medication to shrink his tumors. The patient’s health ...
Solid tumors often contain regions with very low oxygen levels, especially in their inner core. While these hypoxic ...
A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Researchers at The University of Texas MD Anderson Cancer Center have identified an epigenetic target for replication stress, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results